I'm a medical oncologist with a specific focus in gastrointestinal cancers. I have focused on developing novel therapies for patients with liver and bile duct cancers as well as patients with metastases to the liver from colorectal cancer.

I serve as the Chair of the Division of Medical Oncology and as Deputy Director for Clinical Research in the Mayo Clinic Cancer Center.

Medical School

• University of Washington School of Medicine

Residency

• Internal Medicine, Mayo Clinic College of Medicine and Science

Fellowship

• Hematology, Mayo Clinic College of Medicine and Science
• Oncology, Mayo Clinic College of Medicine and Science
• Internal Medicine, Mayo Clinic College of Medicine and Science

Certification

• Medical Oncology, American Board of Internal Medicine

Membership

• Alliance for Clinical Trials in Oncology
• Alliance Foundation Trials
• Mayo Clinic Cancer Center, Office of Research Information Services

Academic Appointment

• Professor of Oncology, Mayo Clinic College of Medicine and Science

• Anal cancer
• Cholangiocarcinoma
• Colon cancer
• Esophageal cancer
• Gallbladder cancer
• Hepatocellular carcinoma
• Liver cancer
• Neuroendocrine tumor
• Pancreatic cancer
• Rectal cancer
• Small bowel cancer
• Stomach cancer

• Impact of diabetes and metformin use on recurrence and outcome in state II-III colon cancer patients - A pooled analysis of three adjuvant trials, May 2022
• N064A (Alliance): Phase II study of panitumumab, chemotherapy, and external beam radiation in patients with locally advanced pancreatic adenocarcinoma, March 2022
• Reevaluating disease-free survival as an endpoint vs. overall survival in Stage III adjuvant colon cancer trials, January 2022
• A genome-wide search for determinants of survival in 1926 patients with advanced colorectal cancer with follow-up in over 22,000 patients, December 2021
• FGFR inhibitor toxicity and efficacy in cholangiocarcinoma: Multicenter single-institution cohort experience, July 2021